Group items tagged

Chronic renal failure, or renal overload, is associated with a variety of morbidity and mortality and is a major challenge in the clinical treatment of patients with chronic renal failure. This disease has no cure and can be managed with specific medications in an appropriate course of therapy. However, in patients for whom other therapies have been ineffective or who are experiencing life-threatening side effects, continuous renal substitute therapy (CRS) is the only feasible treatment. Continuous Renal Replacement Therapy (CRRT) is a type of blood purification therapy used in the treatment of patients with acute kidney injury. The therapy is commonly used to provide renal support for critically ill patients with acute kidney injury, particularly patients who are hemodynamically unstable. Emergence of COVID-19 has led to increasing adoption of CRRT as patients with Covid-19 are experiencing multiple organ failure, including acute kidney injury. Moreover, regulatory bodies are also focused on approval and launch of new CRRT devices. For instance, in April 2020, The U.S. Food and Drug Administration granted marketing authorization for a new device indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients weighing between 2.5 and 10 kilograms (or 5.5 to 22 pounds). Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/demand-for-continuous-renal-replacement.html